Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2013
10/02/2013EP2643020A1 A drug delivery device
10/02/2013EP2643003A1 Vaginal composition based on alkyl polyglucosides
10/02/2013EP2642996A2 Pharmaceutical compositions
10/02/2013EP2642993A1 Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
10/02/2013EP2642985A1 Polymeric matrix of polymer-lipid nanoparticles as a pharmaceutical dosage form
10/02/2013EP2642982A2 Stable cannabinoid compositions and methods for making and storing them
10/02/2013EP2642979A1 A pharmaceutical composition
10/02/2013EP2170930B3 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
10/02/2013EP2151250B1 Vitamin-Targeted imaging agents
10/02/2013CN203220604U Valnemulin long-acting granular pill
10/02/2013CN103339142A Drug delivery material capable of passing through blood-brain barrier, and peptide and use thereof
10/02/2013CN103338790A Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition for preventing or treating diabetes, containing same as active ingredient
10/02/2013CN103338789A Pharmaceutical composition containing drug having poor water solubility
10/02/2013CN103338788A Patch preparation
10/02/2013CN103338774A 口腔崩解片剂 Orally Disintegrating Tablets
10/02/2013CN103338771A Patch preparation
10/02/2013CN103338757A 贴剂及贴剂制剂 Patch and patch preparation
10/02/2013CN103338754A Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
10/02/2013CN103338753A Pharmaceutical compositions of cytidine analogs and methods of use thereof
10/02/2013CN103338752A Risperidone sustained release microsphere composition
10/02/2013CN103338750A Dermal composition comprising polymeric reversed micelle, and method for producing same
10/02/2013CN103338748A Water-soluble preparation containing physiologically active substance and process for production thereof
10/02/2013CN103338746A Composition containing polyunsaturated fatty acid
10/02/2013CN103333896A Nucleic acid aptamer LXL-1 of breast cancer cell MDA-MB-231 and application thereof
10/02/2013CN103333895A Nucleic acid aptamer specifically binding to human epidermal growth factor acceptor III type mutant and applications thereof
10/02/2013CN103333770A Preparation method of pure medicinal red rice with traditional Chinese medicinal materials
10/02/2013CN103333350A Preparation method of sericin microspheres
10/02/2013CN103333349A Hyaluronic acid-collagen composite hydrogel for injection and preparation method thereof
10/02/2013CN103333301A Amphiphilic pH-responsive 4/6 heteroarm star-shaped copolymer and preparation method thereof
10/02/2013CN103333294A High-strength protein-adsorption-resistant aquogel, and preparation method and application thereof
10/02/2013CN103333255A Long-acting HIV-1 (Human Immunodeficiency Virus-1) membrane fusion inhibitor
10/02/2013CN103333253A Nano antibody fusion protein, and preparation method and application thereof
10/02/2013CN103333246A Anti-EGFR tumor growth inhibitor, preparation method thereof and applications thereof
10/02/2013CN103333245A Anti-cell-acceptor and anti-tumor-growth drug molecule, preparation method thereof and applications thereof
10/02/2013CN103333238A mPEG-MAL-aGLP-1 composite
10/02/2013CN103333179A Maytansinoid derivatives, preparation method thereof and applications thereof
10/02/2013CN103330946A 5 alpha- androstane-3 beta, 5,6 beta-triol injection and preparation method thereof
10/02/2013CN103330945A Application of pingyangmycin combined with sodium hyaluronate in drug for treating lymphatic malformation
10/02/2013CN103330944A Bicyclol oral solid pharmaceutical composition, and preparation and preparation method thereof
10/02/2013CN103330943A Bicyclol-containing water-soluble pharmaceutical composition and preparation, and preparation method thereof
10/02/2013CN103330942A Florfenicol smell masking preparation and preparation method thereof
10/02/2013CN103330941A Pharmaceutical composition of paclitaxel injection
10/02/2013CN103330938A Tumor targeting photosensitizers and preparation methods and applications of photosensitizers
10/02/2013CN103330937A Monoclonal antibody-antigen binding segment-T-2 toxin conjugate
10/02/2013CN103330933A Drug composition containing micafungin or salt thereof
10/02/2013CN103330932A Drug composition of micafungin or salt thereof
10/02/2013CN103330770A Preparation method of sugar-free anti-influenza detoxification granule
10/02/2013CN103330734A Medium/long-chain fat emulsion injection pharmaceutical composition and preparation method thereof
10/02/2013CN103330716A Preparation method of trivitamins B tablets
10/02/2013CN103330710A Ramosetron composition for injection
10/02/2013CN103330709A Ondansetron composition for injection
10/02/2013CN103330707A Cimetidine composition for injection
10/02/2013CN103330706A A thrombolytic liquid preparation capable of avoiding fibrinogen degradation and a preparation method thereof
10/02/2013CN103330705A Ranitidine composition for injection
10/02/2013CN103330702A Medicine composition containing imitated sympathetic nerve amine salt and induced gel system
10/02/2013CN103330699A Transdermal drug delivery system
10/02/2013CN103330698A Preparation method for black plaster
10/02/2013CN103330697A Cefprozil capsule and preparation method thereof
10/02/2013CN103330696A Method for preparing colored empty capsules by employing natural colorants
10/02/2013CN103330695A Preparation method for enteric plant cellulose hard hollow capsules
10/02/2013CN103330693A Simvastatin component improving disintegration and preparation method thereof
10/02/2013CN103330692A Simvastatin component improving stability and preparation method thereof
10/02/2013CN103330691A Simvastatin component improving hardness and preparation method thereof
10/02/2013CN103330690A Pharmaceutical composition having improved solubility
10/02/2013CN103330688A Ranitidine freeze-dried powder injection for curing gastropathy
10/02/2013CN103330685A Cefaclor granule and preparation method thereof
10/02/2013CN103330684A Preparation method of diammonium glycyrrhizinate lipid compound effervescent granule
10/02/2013CN103330682A Potassium dehydroandrographolide succinate injection and preparation method
10/02/2013CN103330679A Film coating agent for treating pigeon ectozoa and preparation method thereof
10/02/2013CN103330678A Paeonol tiny sponge preparation and preparation method thereof
10/02/2013CN102614116B Self-emulsifying substrate and application thereof
10/02/2013CN102614114B Vitamin E self-emulsifying ointment
10/02/2013CN102552947B Cation microvesicle and preparation method thereof
10/02/2013CN102532569B Preparation method of yak milk casein edible film
10/02/2013CN102319204B Azithromycin ophthalmic preparation drug composition and preparation method thereof
10/02/2013CN101516403B Orally disintegrating tablet and process for production thereof
10/02/2013CN101346128B Formulation comprising drug of low water solubility and method of use thereof
10/01/2013US8546581 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide
10/01/2013US8546493 Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
10/01/2013US8546487 Cationic poly (amino acids) and uses thereof
10/01/2013US8546453 Propofol compositions and methods for reducing pain associated with propofol injection
10/01/2013US8546419 Dual phase drug release system
10/01/2013US8546384 Bonding tissues and cross-linking proteins with naphthalimide compounds
10/01/2013US8546363 Controlled release corticosteroid compositions and methods for the treatment of otic disorders
10/01/2013US8546334 Device having osteoinductive and osteoconductive properties
10/01/2013US8546319 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
10/01/2013US8546143 Compositions and methods for inhibiting expression of a target gene
10/01/2013US8545927 Lactoferrin-based biomaterials for tissue regeneration and drug delivery
10/01/2013US8545889 Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
10/01/2013US8545887 Modified release dosage forms
10/01/2013US8545876 Modified drugs for use in liposomal nanoparticles
10/01/2013US8545873 Percutaneous absorption type plaster
10/01/2013US8545843 Treatment of vasculitis
10/01/2013US8545840 Methods for treating cancer using an immunotoxin
10/01/2013US8545838 Compositions and methods for cancer immunotherapy
10/01/2013US8545832 Lipid depot formulations
10/01/2013US8545830 Smart segment and a hydrophobic and a hydrophillic biodegradable segment which are hydrolytically or enzymatically degradable; prolonged delivery of therapeutic agents
10/01/2013US8545829 Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
10/01/2013US8545550 Drug-delivery endovascular stent and method for treating restenosis
10/01/2013CA2720516C Indoline anti-cancer agents
1 ... 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 ... 1712